3-Month Dapivirine Vaginal Ring for HIV Prevention Demonstrates Superior Drug Release Compared to 1-Month Ring
By Staff Reporter Lima, Peru – The Population Council, an international nonprofit research organization, announced today at HIVR4P 2024, the 5th HIV Research for Prevention Conference, the results of a phase I open-label randomized crossover relative bioavailability trial (IPM 054). The trial found that a 3-month dapivirine vaginal ring delivers the active antiretroviral drug, dapivirine,
Read MoreWHO approves first mpox diagnostic test for emergency use, boosting global access
By Michael Gwarisa The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing. The approval for emergency use of the Alinity m MPXV assay, manufactured by Abbott Molecular Inc., will be pivotal in expanding
Read MoreGhana To Host ICASA 2025
By Staff Reporter The Society for AIDS in Africa (SAA) is delighted to announce that Ghana has been selected as the host country for the 23rd edition of the International Conference on AIDS and STIs in Africa (ICASA), which will take place in from 3rd to 8th December 2025 at the Accra International Conference Centre.
Read More